Investigation of design and bias issues in case-control studies of cancer screening using microsimulation

American Journal of Epidemiology

Volumn 151, Issue 10, 2000, Pages 991-998

  Connor, Robert J ^a   Boer, Rob ^b   Prorok, Philip C ^a   Weed, Douglas L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Bias; Cancer (epidemiology); Case control studies; Neoplasms

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER SCREENING; CASE CONTROL STUDY; DISEASE SIMULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE;

EID: 0034656903     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010143     Document Type: Article

References (27)

1. Verbeek ALM, Hendriks JHCL, Holland R, et al. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen Project, 1975-1981. Lancet 1984;1:1222-4.
2. Collette HJA, Day NE, Rombach JJ, et al. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet 1984;1:1224-6.
3. Palli D, Del Turco MRD, Buiatti E, et al. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986;38:501-4.
4. Clarke EA, Anderson TW. Does screening by "Pap" smear help prevent cervical cancer? A case-control study. Lancet 1979;2:1-4.
5. Aristizabal N, Cuello C, Correa P, et al. The impact of vaginal cytology on cervical cancer risks in Cali, Columbia. Int J Cancer 1984;34:5-9.
6. MacGregor JE, Moss SM, Parkin DM, et al. A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) 1985;290:1543-6.
7. Celentano DD, Klassen AC, Weisman CS, et al. Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study. J Clin Epidemiol 1988;41:531-41.
8. Oshima A, Hirata N, Ubukata T, et al. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986;38:829-33.
9. Ebeling K, Nischan P. Screening for lung cancer - results from a case-control study. Int J Cancer 1987;40:141-4.
10. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
11. Cronin KA, Weed DL, Connor RJ, et al. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 1998;90:498-504.
12. Berrino F, Gatta G, D'Alto M, et al. Use of case-control studies in evaluation of screening programmes. UICC Tech Rep Ser 1984;78:24-43.
13. Etzioni RD, Weiss NS. Analysis of case-control studies of screening: impact of misspecifying the duration of detectable preclinical pathologic changes. Am J Epidemiol 1998;148: 292-7.
14. Friedman GD, Hiatt RA, Quesenberry CP Jr, et al. Problems in assessing screening experience in observational studies of screening efficacy: example of urinalysis screening for bladder cancer. J Med Screen 1995;2:219-23.
15. Gill TM, Horwitz RI. Evaluating the efficacy of cancer screening: clinical distinctions and case-control studies. J Clin Epidemiol 1995;48:281-92.
16. Hosek RS, Flanders WD, Sasco AJ. Bias in case-control studies of screening effectiveness. Am J Epidemiol 1996;143:193-201.
17. Morrison AS. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol 1982;115:6-8.
18. Moss SM, Case-control studies of screening. Int J Epidemiol 1991;20:1-6.
19. Sasco AJ, Day NE, Walter SD. Case-control studies for the evaluation of screening. J Chronic Dis 1986;39:399-405.
20. Weiss NS. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol 1983;118:457-60.
21. Weiss NS, Lazovich D. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome. Am J Epidemiol 1996; 143:319-22.
22. Weiss NS, McKnight B, Stevens NG. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 1992;135:817-23.
23. Habbema JDF, DeVlas SJ, Plaisier AP, et al. The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. Am J Trop Med Hyg 1996;55:165-9.
24. Habbema JDF, van Oortmarssen GJ, Lubbe JTN, et al. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 1985;20: 79-93.
25. Habbema JDF, Lubbe JTN, van Oortmarssen GJ, et al. A simulation approach to cost effectiveness and cost benefit calculations of screening for early detection of disease. Eur J Operations Res 1987;29:159-66.
26. van Oortmarssen GJ, Habbema JDF, van der Maas PJ, et al. A model for breast cancer screening. Cancer 1990;66:1601-12.
27. SAS Institute Inc. SAS technical report P-217. SAS/STAT software: the PHREG procedure. Version 6. Cary, NC: SAS Institute, Inc., 1991:63.